Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 340

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 340
---
, that any such Potential Asset Disposition will require, to the extent consistent with applicable laws, the prior written consent of Tvardi (which consent shall be in the sole discretion of Tvardi) if such Potential Asset Disposition would create any post-disposition liabilities or indemnity obligations for Cara following Closing; provided, however, that the prior written consent of Tvardi will not be required in connection with any Potential Asset Disposition if Cara agrees that the maximum aggregate dollar value of any post-disposition liabilities or indemnity obligation will be considered as a reduction to Cara Net Cash as set forth in the Merger Agreement. In no event will Cara enter into any Potential Asset Disposition that would result in excess of $100,000 of indemnity obligations or post-disposition Liabilities to, or obligations of, Cara following the Closing. On December 17, 2024, Cara and Royalty Sub, entered into an APA with CSL Vifor, pursuant to which, at the consummation of the transaction, Sellers will sell to CSL Vifor and CSL Vifor will acquire from Sellers certain assets and rights for the development, manufacture and commercialization of difelikefalin as well as certain associated liabilities for a purchase price of $900,000 (subject to certain adjustments with respect to inventory). See “Asset Sale” beginning on page 198 of this proxy statement/prospectus for a more detailed description of this Asset Disposition. Representations and Warranties The Merger Agreement contains customary representations and warranties of the parties. Tvardi represents and warrants to the following matters:

| ● | Due Organization; Subsidiaries |

| ● | Organizational Documents |

182

| ● | Authority; Binding Nature of Agreement |

| ● | Vote Required |

| ● | Non-Contravention; Consents |

| ● | Capitalization |

| ● | Financial Statements |

| ● | Absence of Changes |

| ● | Absence of Undisclosed Liabilities |

| ● | Title to Assets |

| ● | Real Property; Leasehold |

| ● | Intellectual Property |

| ● | Agreements, Contracts and Commitments |

| ● | Compliance; Permits; Restrictions |

| ● | Legal Proceedings; Orders |

| ● | Tax Matters |

| ● | Employee and Labor Matters; Benefit Plans |

| ● | Environmental Matters |

| ● | Insurance |

| ● | No Financial Advisors |

| ● | Disclosure |

| ● | Transactions with Affiliates |

| ● | Anti-Bribery |